Douglas J. Batdorff Sells 3,470 Shares of Kewaunee Scientific Co. (NASDAQ:KEQU) Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) VP Douglas J. Batdorff sold 3,470 shares of the firm’s stock in a transaction dated Monday, December 30th. The stock was sold at an average price of $65.50, for a total transaction of $227,285.00. Following the completion of the sale, the vice president now owns 5,000 shares of the company’s stock, valued at $327,500. This trade represents a 40.97 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Kewaunee Scientific Stock Down 2.6 %

Shares of KEQU stock traded down $1.63 during mid-day trading on Thursday, hitting $60.24. The stock had a trading volume of 11,717 shares, compared to its average volume of 18,181. Kewaunee Scientific Co. has a 12-month low of $27.00 and a 12-month high of $67.20. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.53 and a quick ratio of 2.00. The firm’s 50-day moving average is $44.44 and its two-hundred day moving average is $43.76. The firm has a market capitalization of $173.01 million, a P/E ratio of 9.55 and a beta of 0.80.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised Kewaunee Scientific from a “hold” rating to a “buy” rating in a research note on Wednesday, December 18th.

Institutional Investors Weigh In On Kewaunee Scientific

Large investors have recently modified their holdings of the business. JPMorgan Chase & Co. lifted its holdings in shares of Kewaunee Scientific by 18,000.0% during the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock worth $30,000 after purchasing an additional 900 shares during the period. Geode Capital Management LLC increased its stake in shares of Kewaunee Scientific by 8.9% in the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock worth $792,000 after acquiring an additional 1,941 shares during the period. Ritholtz Wealth Management lifted its position in Kewaunee Scientific by 24.6% during the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock valued at $363,000 after purchasing an additional 2,156 shares during the period. Barclays PLC purchased a new stake in Kewaunee Scientific in the third quarter valued at $121,000. Finally, Heron Bay Capital Management acquired a new stake in Kewaunee Scientific during the 2nd quarter worth about $252,000. Institutional investors own 32.69% of the company’s stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.